This implies that the combination of HSP27 silencing and MET kinase inhibition could more steadily control the growth of MET‐addicted tumours and suggests that a similar mechanism drives full cytotoxicity driven by HSP27 silencing and targeted agents. Here, HSPB1 is linked to neoplasm.